tiprankstipranks
OptiNose Inc: FDA Approval and Future Pediatric Study for XHANCE
PremiumCompany AnnouncementsOptiNose Inc: FDA Approval and Future Pediatric Study for XHANCE
1M ago
Optinose to resume trading at 4:20 pm ET
PremiumThe Fly
Optinose to resume trading at 4:20 pm ET
1M ago
XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps
PremiumPress Releases
XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps
1M ago
Optinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights
PremiumPress ReleasesOptinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights
1M ago
Optinose (OPTN) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Optinose (OPTN) Q4 Earnings Cheat Sheet
2M ago
Optinose Announces Reporting Date for Fourth Quarter 2023 Financial Results
PremiumPress Releases
Optinose Announces Reporting Date for Fourth Quarter 2023 Financial Results
2M ago
Optinose announces 3-month extension of FDA review period for sNDA for XCHANCE
PremiumThe FlyOptinose announces 3-month extension of FDA review period for sNDA for XCHANCE
5M ago
Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference
PremiumPress Releases
Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference
5M ago
Optinose participates in a conference call with Jefferies
PremiumThe Fly
Optinose participates in a conference call with Jefferies
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100